QLDIn ForceAct
Voluntary Assisted Dying Act 2021
sec.65Information to be given before prescribing voluntary assisted dying substance
Start here
Get a plain-English read of sec.65
Turn the raw legal text into a practical explanation grounded in Voluntary Assisted Dying Act 2021.
### sec.65 Information to be given before prescribing voluntary assisted dying substance
The coordinating practitioner for a person who has made a self-administration decision must, before prescribing a voluntary assisted dying substance for the person, inform the person, in writing, of the following—
the S4 substance or S8 substance, or combination of substances, constituting the substance;
that the person is not under any obligation to self-administer the substance;
that the substance must be stored in accordance with requirements prescribed by regulation;
how to prepare and self-administer the substance;
the expected effects of self-administration of the substance;
the period within which the person is likely to die after self-administration of the substance;
the potential risks of self-administration of the substance;
that, if the person decides not to self-administer the substance, their contact person must give the substance to an authorised disposer for disposal;
that, if the person dies, their contact person must give any unused or remaining substance to an authorised disposer for disposal;
the name of the authorised supplier who will be supplying the voluntary assisted dying substance;
the name of 1 or more registered health practitioners or class of registered health practitioners who are authorised disposers.
The coordinating practitioner for a person who has made a practitioner administration decision must, before prescribing a voluntary assisted dying substance for the person, inform the person, in writing, of the following—
the S4 substance or S8 substance, or combination of substances, constituting the substance;
that the person is not under any obligation to have the substance administered to the person;
the method by which the substance will be administered;
the expected effects of administration of the substance;
the period within which the person is likely to die after administration of the substance;
the potential risks of administration of the substance;
that, if the practitioner administration decision is made after the revocation of a self-administration decision, the person’s contact person must give any substance received by the person, the contact person or an agent of the contact person to an authorised disposer for disposal;
if the practitioner administration decision is made after the revocation of a self-administration decision—the name of 1 or more registered health practitioners or class of registered health practitioners who are authorised disposers.
(sec.65-ssec.1) The coordinating practitioner for a person who has made a self-administration decision must, before prescribing a voluntary assisted dying substance for the person, inform the person, in writing, of the following— the S4 substance or S8 substance, or combination of substances, constituting the substance; that the person is not under any obligation to self-administer the substance; that the substance must be stored in accordance with requirements prescribed by regulation; how to prepare and self-administer the substance; the expected effects of self-administration of the substance; the period within which the person is likely to die after self-administration of the substance; the potential risks of self-administration of the substance; that, if the person decides not to self-administer the substance, their contact person must give the substance to an authorised disposer for disposal; that, if the person dies, their contact person must give any unused or remaining substance to an authorised disposer for disposal; the name of the authorised supplier who will be supplying the voluntary assisted dying substance; the name of 1 or more registered health practitioners or class of registered health practitioners who are authorised disposers.
(sec.65-ssec.2) The coordinating practitioner for a person who has made a practitioner administration decision must, before prescribing a voluntary assisted dying substance for the person, inform the person, in writing, of the following— the S4 substance or S8 substance, or combination of substances, constituting the substance; that the person is not under any obligation to have the substance administered to the person; the method by which the substance will be administered; the expected effects of administration of the substance; the period within which the person is likely to die after administration of the substance; the potential risks of administration of the substance; that, if the practitioner administration decision is made after the revocation of a self-administration decision, the person’s contact person must give any substance received by the person, the contact person or an agent of the contact person to an authorised disposer for disposal; if the practitioner administration decision is made after the revocation of a self-administration decision—the name of 1 or more registered health practitioners or class of registered health practitioners who are authorised disposers.
- (a) the S4 substance or S8 substance, or combination of substances, constituting the substance;
- (b) that the person is not under any obligation to self-administer the substance;
- (c) that the substance must be stored in accordance with requirements prescribed by regulation;
- (d) how to prepare and self-administer the substance;
- (e) the expected effects of self-administration of the substance;
- (f) the period within which the person is likely to die after self-administration of the substance;
- (g) the potential risks of self-administration of the substance;
- (h) that, if the person decides not to self-administer the substance, their contact person must give the substance to an authorised disposer for disposal;
- (i) that, if the person dies, their contact person must give any unused or remaining substance to an authorised disposer for disposal;
- (j) the name of the authorised supplier who will be supplying the voluntary assisted dying substance;
- (k) the name of 1 or more registered health practitioners or class of registered health practitioners who are authorised disposers.
- (a) the S4 substance or S8 substance, or combination of substances, constituting the substance;
- (b) that the person is not under any obligation to have the substance administered to the person;
- (c) the method by which the substance will be administered;
- (d) the expected effects of administration of the substance;
- (e) the period within which the person is likely to die after administration of the substance;
- (f) the potential risks of administration of the substance;
- (g) that, if the practitioner administration decision is made after the revocation of a self-administration decision, the person’s contact person must give any substance received by the person, the contact person or an agent of the contact person to an authorised disposer for disposal;
- (h) if the practitioner administration decision is made after the revocation of a self-administration decision—the name of 1 or more registered health practitioners or class of registered health practitioners who are authorised disposers.